In the latest trading session, 14.05 million Tilray Brands Inc (NASDAQ:TLRY) shares changed hands as the company’s beta touched 2.10. With the company’s most recent per share price at $1.16 changed hands at -$0.02 or -1.40% at last look, the market valuation stands at $1.09B. TLRY’s current price is a discount, trading about -156.03% off its 52-week high of $2.97. The share price had its 52-week low at $1.14, which suggests the last value was 1.72% up since then. When we look at Tilray Brands Inc’s average trading volume, we note the 10-day average is 45.31 million shares, with the 3-month average coming to 32.34 million.
Analysts gave the Tilray Brands Inc (TLRY) stock a consensus recommendation rating of Buy, calculated at a mean rating of 2.50. If we narrow down to specifics, the data shows that 1 out of 5 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 2 recommended TLRY as a Hold, 2 felt it is a Buy and 0 rated the stock as Underweight. Tilray Brands Inc’s EPS for the current quarter is expected to be -0.09.
Tilray Brands Inc (NASDAQ:TLRY) trade information
Instantly TLRY was in red as seen in intraday trades today. With action -16.89%, the performance over the past five days has been red. The company’s shares are showing year-to-date downside of -12.52%, with the 5-day performance at -16.89% in the red. However, in the 30-day time frame, Tilray Brands Inc (NASDAQ:TLRY) is -7.66% down. Looking at the short shares, we see there were 114.53 million shares sold at short interest cover period of 3.99 days.
The consensus price target for the stock as assigned by Wall Street analysts is 2.25, meaning bulls need an upside of 48.44% from its recent market value. According to analyst projections, TLRY’s forecast low is 2 with 2.5 as the target high. To hit the forecast high, the stock’s price needs a -115.52% plunge from its current level, while the stock would need to soar -72.41% for it to hit the projected low.
Tilray Brands Inc (TLRY) estimates and forecasts
Data shows that the Tilray Brands Inc share is performing relatively much better than most of its peers within the same industry. As can be gleaned from the statistics, the company’s share value shot -39.08% over the past 6 months, a 57.58% in annual growth rate that is considerably higher than the industry average of -2.60%. Year-over-year growth is forecast to reach 13.54% up from the last financial year.
Consensus estimates given by 9 financial analysts project the company’s revenue in the current quarter to hit an average of 213.78M. 8 analysts are of the opinion that Tilray Brands Inc’s revenue for the current quarter will be 269.07M. The company’s revenue for the corresponding quarters a year ago was 188.34M and 229.88M respectively. According to analysts, the company will likely register a growth in its current quarter sales, forecast at 13.51%. The estimates for the next quarter sales put growth at 17.05%.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 36.51%. The 2025 estimates are for Tilray Brands Inc earnings to increase by 48.76%.
TLRY Dividends
Tilray Brands Inc is expected to release its next quarterly earnings report in February.
Tilray Brands Inc (NASDAQ:TLRY)’s Major holders
If we look at who the major shareholders are, we find that insiders hold 0.67% of Tilray Brands Inc shares while 11.23% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 11.31%. There are 11.23% institutions holding the Tilray Brands Inc stock share, with TOROSO INVESTMENTS, LLC the top institutional holder. As of 2024-06-30, the company held 1.4597% of the shares, roughly 11.01 million TLRY shares worth $18.28 million.
SUSQUEHANNA INTERNATIONAL GROUP, LLP holds the second largest percentage of outstanding shares, with 1.1113% or 8.38 million shares worth $13.92 million as of 2024-06-30.
Among Mutual Funds, the top two as of Sep 30, 2024 were Amplify ETF Tr-Amplify Alternative Harvest ETF and Vanguard Health Care Index Fund. With 9.68 shares estimated at $11.28 million under it, the former controlled 1.07% of total outstanding shares. On the other hand, Vanguard Health Care Index Fund held about 0.29% of the shares, roughly 2.59 shares worth around $3.02 million.
